Aflac Incorporated (AFL)

Market Cap	50.82B
Revenue (ttm)	19.34B
Net Income (ttm)	5.35B
Shares Out	568.22M
EPS (ttm)	9.10
PE Ratio	9.83
Forward PE	13.62
Dividend	$2.00 (2.24%)
Ex-Dividend Date	May 21, 2024

Volume	1,567,059
Open	88.47
Previous Close	89.06
Day's Range	88.20 - 89.51
52-Week Range	69.00 - 91.15
Beta	0.95
Analysts	Hold
Price Target	83.50 (-6.63%)
Earnings Date	Jul 31, 2024

About AFL

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term ...

• Industry: Insurance - Life
• Sector: Financials
• Founded: 1955
• Employees: 12,785
• Stock Exchange: NYSE
• Ticker Symbol: AFL

Financial Performance

In 2023, Aflac's revenue was $18.70 billion, a decrease of -2.29% compared to the previous year's $19.14 billion. Earnings were $4.66 billion, an increase of 5.45%.

Analyst Forecast

According to 12 analysts, the average rating for AFL stock is "Hold." The 12-month stock price forecast is $83.5, which is a decrease of -6.63% from the latest price.

Price Target

$83.5

(-6.63% downside)

Analyst Consensus: Hold